Neochem Bio Solutions Limited IPO

Apply 0
Avoid 0

Neochem Bio Solutions Limited is a specialty performance chemical manufacturer with a legacy of more than four decades. The company develops over 350 customized formulations across four product categories—Polymers, Surfactants, Silicones and Esters & Bio-based Sustainable Solutions. Its solutions cater to a wide range of industries such as textile and garment washing, home & personal care, institutional and industrial cleaners, water treatment, paints and coatings, paper & pulp, construction, rubber and dyes & pigments.

Product Portfolio & Industry Applications

Neochem offers a diversified solution-based portfolio, including:

1. Textile and garment washing auxiliaries used in pre-treatment, dyeing, finishing, printing and coating.
2. Specialty performance chemicals for home and personal care such as dispersant polymers, anti-foams, silicone emulsions, and surfactants.
3. Water treatment products including anti-scalants, dispersants, anti-foams, de-colorants and flocculants.
4. Additives for paints and coatings, such as acrylic dispersants, wax-emulsion modifiers and acrylic emulsions.
5. Formulated solutions for institutional and industrial cleaning, including laundry, kitchen and personal hygiene applications.

Manufacturing Facility

The company’s production unit is located at Saket Industrial Estate, Moraiya (Sanand), Ahmedabad, with an installed capacity of 22,000 MTPA. The facility is designed for flexible batch manufacturing of liquid and powder-based chemistries and supported by storage capacity of approximately 1,350 MT. The partially automated plant enables efficient and sustainable production.

R&D and Sustainability Focus

Neochem’s product development is supported by an in-house R&D laboratory and Application Research Center, equipped with advanced testing infrastructure. The company focuses on sustainable chemistry and bio-based solutions tailored to customer requirements, enabling innovative product customization and environmentally compliant formulations.

Sales & Distribution Network

The company supplies products directly to customers and through a network of 50+ authorised distributors across India and a reselling agent, Neochem Specialties, owned by the promoter. It also exports products directly to global customers. In India, the company served 254 clients in FY 2024 and continues to expand its customer base across industries and geographies.

Objects of the Neochem Bio Solutions Limited IPO:

Company intends to utilize the proceeds for the following objects: 1. Funding the long-term working capital requirements (₹23.90 cr) 2. Repayment/prepayment, in full or part, of all or certain outstanding borrowings (₹10 cr) 3. General Corporate Purposes.

Neochem Bio Solutions Limited IPO Details:

Open Date: Dec 02 2025
Close Date: Dec 04 2025
Total Shares: 45,88,800
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 44.97 Cr.
Lot Size: 1200 Shares
Issue Price: ₹ 93-98 Per Equity Share
Listing At: NSE Emerge
Listing Date: Dec 09 2025

Promoters And Management:

1. Swapnil Rameshbhai Makati, Managing Director, a Post Graduate Diploma holder in Chemical Engineering from Nirma Institute, he has over 20 years of experience in manufacturing and trading specialty chemicals. Associated with the company since inception, he leads its strategic direction and oversees production, management, and finance. In 2025, he changed his name from “Swapnil R. Dathia” to “Swapnil R. Makati.” 2. Hemangini Swapnil Dathia, Whole-Time Director, a Chemical Engineering diploma holder from Nirma Institute with an MBA, she has been associated with the company for over 16 years. She has played a key role in managing HR and supporting operational functions since the business transitioned from partnership to a company. 3. Dinesh Chopra, Chairman & Non-Executive Director, a B.Sc. (Tech) graduate from UDCT, Mumbai, with additional qualifications in management, he brings around 25 years of leadership experience. Previously associated with BASF India and Honeywell India International in senior roles, he has been with the company since 2021 and contributes to strategic and corporate governance initiatives.

Financials of Neochem Bio Solutions Limited IPO:

Particulars 6M FY2025-26 FY 2024-25 FY 2023-2024 FY 2022-2023
Revenue from Operations (Cr) 45.83 84.17 61.14 48.18
EBITDA (Cr) 8.59 13.11 5.99 4.22
EBITDA Margins 18.75% 15.58% 9.80% 8.77%
PAT (Cr) 5.48 7.75 1.8 1.07
PAT Margins 11.62% 9.00% 2.91% 2.20%
ROCE 22.84% (not annualized) 41.67% 21.46% 17.46%
OPerating Cash Flow -7.68 2.59 1.96 -0.74
D/E Ratio 1.2 1.8 2.78 3.26

Comparison With Peers:

Companies Revenue (in cr) EBITDA Margins PAT Margins ROCE D/E Ratio MCap (in cr) P/E
Neochem Bio Solutions Limited 84.17 15.58% 9.00% 41.67% 1.8 167.78 21.65
Rossari Biotech Limited 2080 13% 6.54% 15.80% 0.28 3318 24.30
Indian Emulsifiers Limited 101 19% 12.87% 23.60% 0.35 193 11.60
NOTE:Forward P/E 15.30 is According to FY 2026 PAT

Lead Manager of Neochem Bio Solutions Limited IPO:

  1. Vivro Financial Services Private Limited

Registrar of Neochem Bio Solutions Limited IPO:

  1. MUFG Intime India Private Limited

Discussion on Neochem Bio Solutions Limited IPO:

Leave a Reply